Myriad Genetics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.29

+0.27 (+4.49%)

As of Nov 7, 2:03 AM ET ·

Analyst Consensus

Sell

Analysts

High

Coverage

Buy 2 13%

Hold 8 53%

Sell 5 33%

Price Target

Analyst Price Target +558.8% upside

Low Target $29.39

Average Target $41.44

High Target $63.29

Current Price $6.29

Current
$6.29

Target
$41.44

$29.39 $41.44 avg $63.29

Scenario Analysis

Bear Case

$29.39

367.2%

Low target

Base Case

$41.44

+558.8%

Avg target

Bull Case

$63.29

+906.2%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$8.09

-22.2% from high

52-Week Low

$2.74

+129.6% from low

Target vs 52W High

$41.44

+412.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%